Drug Profile
Prodocelesine
Alternative Names: MeOH-Pro-12; Pro-12Latest Information Update: 03 Sep 2002
Price :
$50
*
At a glance
- Originator PharmaMar
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 07 Oct 1999 Pro-12 is now called prodocelesine
- 07 Oct 1999 Preclinical development for Cancer in Spain (Unknown route)
- 07 Oct 1999 Preclinical development for Cancer in USA (Unknown route)